Hepatitis C virus inhibitors
US8618153B2 · kind B2 · utility
6Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 12, 2012 |
| Grant date | Dec 31, 2013 |
| Priority date | — |
| Expiry date | Sep 12, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This disclosure concerns novel compounds of Formula (I) or as defined in the specification and compositions comprising such novel compounds. These compounds are useful antiviral agents, especially in inhibiting the function of the NS5A protein encoded by Hepatitis C virus (HCV). Thus, the disclosure also concerns a method of treating HCV related diseases or conditions by use of these novel compounds or a composition comprising such novel compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.